Papp L Roy & Associates Eli Lilly & CO Transaction History

Papp L Roy & Associates

$822 Million
Q2 2024

A detailed history of Papp L Roy & Associates transactions in Eli Lilly & CO stock. As of the latest transaction made, Papp L Roy & Associates holds 2,380 shares of LLY stock, worth $2.16 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

2,380

Previous 2,428 1.98%

Holding current value

$2.16 Million

Previous $1.89 Million 14.09%

% of portfolio

0.26%

Previous 0.23%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $34,793 - $43,633	-48 Reduced 1.98%	2,380 $2.15 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $38,493 - $51,498	-65 Reduced 2.61%	2,428 $1.89 Million
Q4 2023 Jan 19, 2024	BUY	$525.19 - $619.13 $5,251 - $6,191	10 Added 0.4%	2,493 $1.45 Million
Q3 2023 Oct 18, 2023	SELL	$434.7 - $599.3 $21,735 - $29,964	-50 Reduced 1.97%	2,483 $1.33 Million
Q2 2023 Jul 17, 2023	SELL	$350.74 - $468.98 $57,521 - $76,912	-164 Reduced 6.08%	2,533 $1.19 Million
Q1 2023 May 05, 2023	SELL	$310.63 - $364.82 $55,602 - $65,302	-179 Reduced 6.22%	2,697 $926,000
Q3 2022 Oct 21, 2022	BUY	$296.48 - $337.87 $505,498 - $576,068	1,705 Added 145.6%	2,876 $930,000
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $469 - $583	-2 Reduced 0.17%	1,171 $335,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $449 - $558	2 Added 0.17%	1,173 $324,000
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $22,160 - $27,270	-100 Reduced 7.87%	1,171 $271,000
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $95,305 - $123,377	-580 Reduced 31.33%	1,271 $237,000
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $10,306 - $13,637	79 Added 4.46%	1,851 $313,000
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $17,052 - $20,522	125 Added 7.59%	1,772 $291,000
Q1 2020 May 05, 2020	SELL	$119.05 - $147.35 $11,905 - $14,735	-100 Reduced 5.72%	1,647 $228,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $186,789 - $231,355	1,747 New	1,747 $230,000
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $209,628 - $228,022	-1,963 Closed	0 $0
Q1 2019 May 09, 2019	SELL	$111.31 - $131.02 $54,875 - $64,592	-493 Reduced 20.07%	1,963 $255,000
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $37,065 - $41,524	-350 Reduced 12.47%	2,456 $284,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $36,490 - $45,606	425 Added 17.85%	2,806 $301,000
Q2 2018 Aug 09, 2018	BUY	$75.7 - $86.88 $180,241 - $206,861	2,381 New	2,381 $203,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $185,970 - $219,525	-2,506 Closed	0 $0
Q4 2017 Feb 06, 2018	BUY	$81.94 - $87.89 $2,048 - $2,197	25 Added 1.01%	2,506 $212,000
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $191,210 - $212,224	2,481	2,481 $212,000

Others Institutions Holding LLY

# of Institutions

3,887

Shares Held

763M

Call Options Held

6.34M

Put Options Held

7.97M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $864B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Papp L Roy & Associates with notifications on news.

Account

Papp L Roy & Associates Eli Lilly & CO Transaction History